滚动资讯
CellMitochondrial control of glycerolipid synthesis by a PEP shuttleCellFunctional RNA splitting drove the evolutionary emergence of type V CRISPR-Cas systems from transposonsCellDeep-learning-based <em>de novo</em> discovery and design of therapeutics that reverse disease-associated transcriptional phenotypesCellFour centuries of commercial whaling eroded 11,000 years of population stability in bowhead whalesFierceBiotechBeyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndromeEndpoints NewsLawmakers signal willingness to counter China’s biotech gainsEndpoints NewsSanofi, AbbVie, Novartis and AstraZeneca face revived 340B pricing caseEndpoints NewsFDA opens door to RMAT designations for therapies on clinical holdEndpoints NewsFDA seeks to encourage fewer animal studies with new draft guidanceBioPharma DiveRBC: Revolution, Xenon, Arrowhead among top takeover targetsBioPharma DiveJ&J wins FDA nod for psoriasis pill that aims to compete with top-selling injectionsFierceBiotechJenaValve的Trilogy瓣膜获得FDA首个主动脉反流适应症批准。
Endpoints News 2026年1月30日

Janux任命首席营销官，此前与百时美施贵宝达成T细胞衔接器协议；Lexeo一批新任命出炉

Janux任命首席营销官，此前与百时美施贵宝达成T细胞衔接器协议；Lexeo一批新任命出炉

原文
暂时没有全文，请查看原始来源。

目录

59 全部